[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Pages 9523-9524]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03019]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR18-877: Alzheimer's Disease Clinical Trials.
    Date: March 10, 2021.
    Time: 9:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sara Louise Hargrave, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institute of Health, 
6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301) 443-7193, 
[email protected].

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Biostatistical Methods and Research Design 
Study Section.
    Date: March 10-12, 2021.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Victoriya Volkova, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3140, Bethesda, MD 20892, (301) 594-7781, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Biostatistical Methods and Research Design.
    Date: March 12, 2021.
    Time: 9:30 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Seetha Bhagavan, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 
20892, (301) 237-9838, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Cancer Diagnostics and Treatments (CDT).
    Date: March 15-16, 2021.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Maria Elena Cardenas-Corona, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 867-5309, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, PAR Panel: Community Interventions to Address the 
Consequences of the COVID-19 Pandemic Among Health Disparity and 
Vulnerable Populations.
    Date: March 15-16, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Pia Kristina Peltola, Ph.D., Scientific Review 
Officer, Center for Scientific Review, 6701 Rockledge Drive, 
Bethesda, MD 20892, (301) 435-1266, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Disease Prevention and Management, Risk 
Reduction and Health Behavior Change.
    Date: March 15-16, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael J. McQuestion, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD 
20892, (301) 480-1276, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Infectious Diseases and Immunology Research Enhancement 
Review.
    Date: March 15, 2021.
    Time: 9:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Liangbiao Zheng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD 
20892, (301) 996-5819, [email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; HIV/AIDS Intra- and Inter-personal 
Determinants and Behavioral Interventions Study Section.
    Date: March 15-16, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mark P. Rubert, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 
20892, (301) 806-6596, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Electronic Nicotine Delivery Systems (ENDS): 
Population, Clinical and Applied Prevention Research.
    Date: March 15, 2021.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Miriam Mintzer, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD 
20892, (301) 523-0646, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; SBIR/STTR Applications in Drug Discovery and Development.
    Date: March 15-16, 2021.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sergei Ruvinov, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 
20892, (301) 435-1180, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Electronic Nicotine Delivery Systems (ENDS): 
Population, Clinical and Applied Prevention Research.
    Date: March 15, 2021.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mark A. Vosvick, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3110,

[[Page 9524]]

Bethesda, MD 20892, (301) 402-4128, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 9, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-03019 Filed 2-12-21; 8:45 am]
BILLING CODE 4140-01-P